Carson Wealth (CWM LLC)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.3M Sell
332,096
-22,828
-6% -$3.2M 0.12% 165
2025
Q4
$43.6M Buy
354,924
+513
+0.1% +$62.3K 0.12% 161
2025
Q3
$39.3M Buy
354,411
+2,716
+0.8% +$309K 0.12% 152
2025
Q2
$39M Buy
351,695
+18
+0% +$1.92K 0.14% 136
2025
Q1
$39.4M Sell
351,677
-12,808
-4% -$1.32M 0.16% 125
2024
Q4
$33.7M Sell
364,485
-790
-0.2% -$71.1K 0.14% 134
2024
Q3
$30.6M Sell
365,275
-26,557
-7% -$2.03M 0.13% 140
2024
Q2
$26.9M Buy
391,832
+16,616
+4% +$1.11M 0.13% 149
2024
Q1
$27.5M Sell
375,216
-3,906
-1% -$300K 0.13% 153
2023
Q4
$30.7M Sell
379,122
-12,469
-3% -$970K 0.17% 122
2023
Q3
$29.3M Buy
391,591
+2,782
+0.7% +$214K 0.18% 112
2023
Q2
$30M Sell
388,809
-45,858
-11% -$3.66M 0.19% 108
2023
Q1
$36.1M Sell
434,667
-76,539
-15% -$6.34M 0.24% 79
2022
Q4
$43.9M Buy
511,206
+4,852
+1% +$384K 0.32% 59
2022
Q3
$31.2M Buy
506,354
+15,603
+3% +$984K 0.25% 81
2022
Q2
$30.3M Buy
490,751
+31,516
+7% +$1.95M 0.24% 87
2022
Q1
$27.3M Buy
459,235
+8,499
+2% +$543K 0.19% 102
2021
Q4
$32.7M Buy
+450,736
New +$31M 0.23% 79
2021
Q2
$6.17M Hold
89,581
0.05% 260
2021
Q1
$6.17M Hold
89,581
0.05% 260
2020
Q4
$6.17M Hold
89,581
0.05% 260
2020
Q3
$6.17M Hold
89,581
0.05% 260
2020
Q2
$6.17M Hold
89,581
0.05% 260
2020
Q1
$6.17M Hold
89,581
0.05% 260
2019
Q4
$6.17M Hold
89,581
0.05% 260
2019
Q3
$6.17M Hold
89,581
0.05% 260
2019
Q2
$6.17M Hold
89,581
0.05% 260
2019
Q1
$6.17M Buy
89,581
+35,397
+65% +$2.35M 0.05% 260
2018
Q4
$3.39M Sell
54,184
-7,016
-11% -$490K 0.08% 203
2018
Q3
$4.72M Buy
61,200
+21,601
+55% +$1.63M 0.12% 169
2018
Q2
$2.81M Sell
39,599
-56,420
-59% -$3.98M 0.09% 180
2018
Q1
$7.24M Buy
96,019
+12,806
+15% +$1.02M 0.29% 78
2017
Q4
$5.96M Buy
83,213
+2,009
+2% +$153K 0.26% 75
2017
Q3
$6.58M Sell
81,204
-2,766
-3% -$212K 0.31% 62
2017
Q2
$5.94M Buy
83,970
+48,672
+138% +$3.24M 0.3% 61
2017
Q1
$2.4M Sell
35,298
-913
-3% -$64.2K 0.14% 133
2016
Q4
$2.59M Buy
36,211
+33,117
+1,070% +$2.46M 0.16% 128
2016
Q3
$245K Buy
3,094
+137
+5% +$11.1K 0.02% 246
2016
Q2
$247K Buy
2,957
+17
+0.6% +$1.51K 0.02% 233
2016
Q1
$270K Hold
2,940
0.02% 213
2015
Q4
$297K Buy
2,940
+140
+5% +$14.6K 0.03% 200
2015
Q3
$275K Hold
2,800
0.03% 194
2015
Q2
$328K Hold
2,800
0.03% 153
2015
Q1
$275K Hold
2,800
0.03% 164
2014
Q4
$264K Hold
2,800
0.03% 158
2014
Q3
$298K Hold
2,800
0.04% 161
2014
Q2
$232K Sell
2,800
-191
-6% -$14.9K 0.04% 168
2014
Q1
$212K Sell
2,991
-57
-2% -$4.47K 0.03% 134
2013
Q4
$229K Sell
3,048
-4
-0.1% -$279 0.04% 158
2013
Q3
$192K Buy
+3,052
New +$182K 0.05% 133

Other funds holding GILD

Carson Wealth (CWM LLC)'s GILD Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Gilead Sciences (GILD) stake by 6.4% in Q1 2026, selling an estimated $3.2M and leaving 332,096 shares worth $46.3M. The position accounts for 0.12% of the portfolio, ranked #165.

Carson Wealth (CWM LLC) first reported a position in GILD in Q3 2013 and has held it in 50 quarters since. 2,318 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Carson Wealth (CWM LLC) held 332,096 shares of Gilead Sciences worth $46.3M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 22,828 Gilead Sciences shares in Q1 2026, an estimated $3.2M.
  • Gilead Sciences made up 0.12% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #165 holding.
  • Carson Wealth (CWM LLC) first reported a position in Gilead Sciences in Q3 2013 and has held it in 50 quarters since.
  • 2,318 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.